September 2019 FDA Recall Drug by Akorn, Inc.
D-1878-2019 - cGMP Deviations

This Class II drug recall was voluntarily initiated by Akorn, Inc. on September 17, 2019 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1878-2019

Reason for Recall
cGMP Deviations: firm reported finding metal particulate matter in the filling room near the tube feeder during the filling operation of the product. No particulates were identified in the product, but rather were identified on the filling line.
Initiated
09-17-2019
Reported
10-02-2019
Quantity
10,543 tubes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide within the United States and Puerto Rico
Lidocaine Hydroclhoride Jelly USP, 2%, 30 mL tubes, Rx Only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-711-30

Batch or Lot Expiration Information

Lot# : 9B21A, Exp. 1/2022